Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortSelective JAK1 inhibitor for arthritis, eczema and inflammatory bowel disease.Oral JAK inhibitor for rheumatoid arthritis, eczema and alopecia areata.
Body systemJoints & ImmunityJoints & Immunity
Drug classJAK inhibitorsJAK inhibitors
SupplyPrescription onlyPrescription only
Main usesRheumatoid arthritis, Psoriatic arthritis, Atopic dermatitis (eczema), Crohn's disease, Ulcerative colitisRheumatoid arthritis, Atopic dermatitis (eczema), Alopecia areata, Hospitalised COVID-19
How it worksCalms immune signalling inside cells.Calms immune signalling inside cells.
Starts workingWeeksWeeks
Half-lifeAbout 8–14 hoursAbout 12 hours
Typical adult dose15 mg once a day (arthritis); higher doses in eczema and IBD.4 mg once a day (2 mg if risk factors or after response).
FormsExtended-release tabletTablet
Common side effectsUpper respiratory infections, Acne, Nausea, Raised cholesterol, Cold soresUpper respiratory infections, Raised cholesterol, Nausea, Cold sores
Serious side effectsSerious infections, Blood clots, Heart attack and stroke, Cancers, Bowel perforationSerious infections, Blood clots, Heart attack and stroke, Cancers
Don't take ifActive serious infection; Active TB; Pregnancy; Severe liver impairmentActive serious infection; Active TB; Pregnancy; Severe liver impairment
AlcoholBest to limit. Alcohol may add to liver strain.Best to limit. Alcohol may add to liver strain.
PregnancyUsually avoidedAvoid in pregnancy.Usually avoidedAvoid in pregnancy.
BreastfeedingUsually avoidedAvoid.Usually avoidedAvoid.
In use since——
Brand namesUnited States: RinvoqUnited Kingdom: RinvoqIndia: RinvoqUnited States: OlumiantUnited Kingdom: OlumiantIndia: Olumiant, Bariciti, Baricitinib (generic)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeL04AA44L04AA37

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker